Advertisement
Advertisement
At close: 04:00PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 223.40 |
| Open | 225.69 |
| Bid | 234.65 x 800 |
| Ask | 234.77 x 900 |
| Day's Range | 231.13 - 236.09 |
| 52 Week Range | 188.10 - 255.93 |
| Volume | |
| Avg. Volume | 473,566 |
| Market Cap | 23.535B |
| Beta (5Y Monthly) | 0.64 |
| PE Ratio (TTM) | 85.56 |
| EPS (TTM) | 2.75 |
| Earnings Date | Jan 31, 2022 - Feb 04, 2022 |
| Forward Dividend & Yield | 1.72 (0.80%) |
| Ex-Dividend Date | Jun 13, 2022 |
| 1y Target Est | 263.80 |
- Zacks
Here's Why You Should Hold STERIS (STE) Stock in Your Portfolio
Investors are optimistic about STERIS (STE) due to its strong fiscal fourth-quarter results.
- Zacks
STERIS (STE) Q4 Earnings Surpass Estimates, Gross Margin Rises
Robust performances across all four reporting segments drive STERIS' (STE) fiscal fourth-quarter revenues.
- GlobeNewswire
STERIS Announces Financial Results for Fiscal 2022 Fourth Quarter and Full Year
Fourth quarter revenue increases 39% as reported; 11% constant currency organicAs reported EPS of $0.52; adjusted EPS of $2.04Company provides FY23 outlook DUBLIN, IRELAND, May 11, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2022 fourth quarter ended March 31, 2022. Revenue as reported for the quarter increased 39% to $1.2 billion compared with $873.5 million in the fourth quarter of fiscal 2021. Constant currency o
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
